Michael A Metzger sold $785K of Syndax Pharmaceuticals (SNDX)

Executed Jul 8, disclosed Jul 9, 1 day later.

Value, as filed

$785K

32,375 sh × $24.24

Executed

Jul 8

the trade date, as filed

Disclosed

Jul 9

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Michael A Metzger Chief Executive Officer profile →

Michael A Metzger (Chief Executive Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Syndax Pharmaceuticals, Inc. (SNDX). The largest single filing was $785K of SNDX (32,375 sh × $24.24, as filed), executed Jul 8.

The name

SNDX

Syndax Pharmaceuticals, Inc. SNDX · Healthcare · 10 filings in 24 months ticker →

Healthcare · Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Michael A Metzger in SNDX

SNDXSALE Syndax Pharmaceuticals, Inc. $130K
6,847 sh × $18.99
Exec Jun 1
Filed Jun 2 · 5:30 PM ET SNDXSALE Syndax Pharmaceuticals, Inc. $361K
17,159 sh × $21.03
Exec Feb 9
Filed Feb 10 · 5:30 PM ET SNDXSALE Syndax Pharmaceuticals, Inc. $153K
7,412 sh × $20.62
Exec Feb 6
Filed Feb 6 · 5:30 PM ET SNDXSALE Syndax Pharmaceuticals, Inc. $2.6M
157,307 sh × $16.41
Exec Sep 8 2025
Filed Sep 8 2025 · 5:30 PM ET SNDXSALE Syndax Pharmaceuticals, Inc. $118K
7,814 sh × $15.05
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET SNDXSALE Syndax Pharmaceuticals, Inc. $206K
13,288 sh × $15.50
Exec Feb 10 2025
Filed Feb 12 2025 · 5:30 PM ET